Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-009322
Filing Date
2024-12-02
Accepted
2024-12-02 16:41:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4053
  Complete submission text file 0001950047-24-009322.txt   5512
Mailing Address C/O REPLIMUNE GROUP, INC. 18 COMMERCE WAY WOBURN MA 01801
Business Address
Esposito Pamela (Reporting) CIK: 0001744425 (see all company filings)

Type: 144

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Subject) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39460 | Film No.: 241519678
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)